HaploPharma Overview

  • Founded
  • 2004

Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

HaploPharma General Information

Description

Provider of biotechnology services intended to serve pharmaceutical companies. The company offers services including planning, research, development, and dissemination of pharmaceuticals, diagnostics, health foods, diagnostic equipment, and medical equipment for pharmaceutical research, development, and medical diagnostics, enabling clients to have health support services.

Contact Information

Website
www.haplopharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 468-1 Aramaki Aza Aoba
  • Aoba-ku, Miyagi Prefecture
  • Sendai, 980-8575
  • Japan
+81 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HaploPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 01-Nov-2020 Completed Generating Revenue
1. Early Stage VC 01-Jan-2007 Completed Generating Revenue
To view HaploPharma’s complete valuation and funding history, request access »

HaploPharma Patents

  • 4

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

HaploPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1849865-A1 Rnai medicine having no adverse effects Active 28-Jan-2005 0000000000
EP-1849865-B1 Rnai medicine having no adverse effects Inactive 28-Jan-2005 0000000000
US-20090035861-A1 Rnai medicine having no adverse effects Inactive 28-Jan-2005 0000000000
EP-1849865-A4 Rnai medicine having no adverse effects Active 28-Jan-2005 C12N15/111

HaploPharma Executive Team (4)

Name Title Board Seat Contact Info
Yasuhisa Nemoto Ph.D Co-Chief Executive Officer & President
Mitsuo Itakura Ph.D Chief Scientific Officer
Koichi Nomoto Director, Finance and Administration & Member of Supervisory Board
Yoshihiro Ohtaki Ph.D Founder, Co-Chief Executive Officer, President & Supervisory Board Member
To view HaploPharma’s complete executive team members history, request access »

HaploPharma Board Members (4)

Name Representing Role Since
Hiroshi Gushima Ph.D Self Chairman 000 0000
Koichi Nomoto HaploPharma Director, Finance and Administration & Member of Supervisory Board 000 0000
Shumpei Ishikawa Ph.D HaploPharma Supervisory Board Member and Senior Scientific Advisor 000 0000
Yoshihiro Ohtaki Ph.D Self Founder, Co-Chief Executive Officer, President & Supervisory Board Member 000 0000
To view HaploPharma’s complete board members history, request access »

HaploPharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HaploPharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Tohoku University Venture Partners Venture Capital Minority 000 0000 000000 0
Bio Frontier Partners Venture Capital Minority 000 0000 000000 0
To view HaploPharma’s complete investors history, request access »

Ready to get started?

Request a free trial